Silvana Novelli

@snovellic

Hematologist at . & many other more relevant things

Barcelona, Spain
Vrijeme pridruživanja: siječanj 2014.

Tweetovi

Blokirali ste korisnika/cu @snovellic

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @snovellic

  1. Prikvačeni tweet
    11. stu 2019.
    Poništi
  2. proslijedio/la je Tweet
    1. velj

    Cord-blood derived CD19-CAR modified NK cells induce remissions in B cell malignancies. February 6, 2020 issue of NEJM in print. Congrats to Katy Rezvani and the whole group! Stay tuned for online issue. NK cell immunotherapy works without CRS or ICANS!

    Poništi
  3. 26. sij

    therapy🏁This article has a lot of relevant information for our daily practice. Even though immunotherapy is routinely administrated in our units, we should always be alert ⚠️ to side effects

    Poništi
  4. 26. sij

    BCMA-bite for R/R shows promising results (70% ORR in MTD group), fast and deep responses. Now it's time to ask: for how long?

    Poništi
  5. proslijedio/la je Tweet
    24. sij

    Our guidelines are now available as a resource to guide physicians in providing the best care for patients

    Poništi
  6. proslijedio/la je Tweet
    10. sij

    I see a good hope for our lymphoma patients from bispecific development

    Poništi
  7. 10. sij

    study: patients with DLBCL with age adjusted IPI of 0 and w/o bulky disease can safely receive RCHOPx4+R2

    Poništi
  8. proslijedio/la je Tweet

    Save the date! Next Monday, 13th, at Auditorium, , from the Department of of , will explain why females make a good egg!

    Poništi
  9. proslijedio/la je Tweet
    6. sij

    Phase 3 randomized controlled trial suggests that a 5-mg dose of olanzapine is effective at controlling chemo-induced nausea but does not have the sedation side effect of a 10-mg dose.

    Poništi
  10. proslijedio/la je Tweet
    4. sij

    Conconi et al prognostic in another indolent B cell lymphoma - this time extranodal marginal zone lymphoma Early POD 69/384 (18%) in IELSG19 high-risk MALT-IPI more likely->POD24 10y OS 64% in early POD vs 85% in others (HR 2.42) Confirmed in validation set

    Poništi
  11. 3. sij

    Higher density of protumoral TAM-M2 in non-CR patients treated with ibru: a possible new prognostic factor to response in

    Poništi
  12. proslijedio/la je Tweet

    Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature ⁦

    Poništi
  13. 29. pro 2019.

    What’s behind every minute we spend in social networks?

    Poništi
  14. proslijedio/la je Tweet

    This charming conical flask-carrying robot was created by a 3D printer capable of printing with multiple different materials, at a speed and level of detail that was previously impossible. And in the future it could have some, well, slightly more useful applications...

    Poništi
  15. proslijedio/la je Tweet

    Stem-like T cells reside in dense antigen-presenting-cell niches within tumour and give rise to terminally diff effector daughter cells; effector differentiation process is crucial for abundant T cells to infiltration of the tumour

    Poništi
  16. 19. pro 2019.

    Don’t forget prevalent diseases even in rare scenarios

    Poništi
  17. 18. pro 2019.

    Thanks to the strike I will generate 5100 Kg of CO2 by plane vs 3.31. 😖 I guess some won’t be able to taste their planned retirement.

    Poništi
  18. 17. pro 2019.

    Low vitamin D levels might have and impact on chemo response in Hodgkin lymphoma through an effect on doxorubicin and etoposide in mouse models.

    Poništi
  19. proslijedio/la je Tweet
    11. pro 2019.

    IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling

    Poništi
  20. 8. pro 2019.

    Thank you for presenting our work: Now let go for the next one!!!!

    Poništi
  21. proslijedio/la je Tweet
    8. pro 2019.

    Wang • DDGP V SMILE in extranodal NKT • superior results & less tox with DDGP Great to have randomised data (albeit small trial) in this disease. SMILE 😊 should be ☹️ as it’s days are surely numbered.

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·